CRYSTAL BOHANNON: Open Payments
NPI 1457738387 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,730 in 141 payments from 19 companies in 2025. Trend: 2023 $1,379 · 2024 $1,848 · 2025 $2,730
Food & beverage: $2,730
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 18 | $568 |
| ABBVIE INC. | 34 | $562 |
| PFIZER INC. | 28 | $345 |
| Novo Nordisk Inc | 15 | $259 |
| Medtronic, Inc. | 1 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $144 |
| Axsome Therapeutics, Inc. | 5 | $105 |
| Otsuka America Pharmaceutical, Inc. | 5 | $96 |
| Lilly USA, LLC | 5 | $78 |
| Phathom Pharmaceuticals, Inc. | 3 | $61 |
Products named: General - Thrombectomy, VRAYLAR, NURTEC ODT, ELUVIA, UBRELVY, SYMPLICITY G3, CAPLYTA, REXULTI.
Industry payments across KY — which companies pay providers there.
